Chee‐Keong Toh
395 works · 5,491 citations · h-index 32
Top works
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)
- Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity
- The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer
- Genomic landscape of lung adenocarcinoma in East Asians
- The Changing Epidemiology of Lung Cancer
- Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma
- Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adults
- Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing
- Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
- 16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC)
- A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
- Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients
- Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis
- Continued Response to One Dose of Nivolumab Complicated by Myasthenic Crisis and Myositis
- Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma
- Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
- The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma
- Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5‐fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma
- Lung cancer in never-smokers